(1->4)-beta-D-glucan multiple interactions ISO Retreg1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RETREG1 mRNA CTD PMID:36331819 (2,4,5-trichlorophenoxy)acetic acid decreases expression ISO Retreg1 (Mus musculus) 6480464 2 more ... CTD PMID:18579281 1,2-dimethylhydrazine decreases expression ISO Retreg1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of FAM134B mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Retreg1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of RETREG1 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RETREG1 (Homo sapiens) 6480464 Estradiol results in increased expression of RETREG1 mRNA CTD PMID:23019147 and PMID:24758408 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of FAM134B mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of RETREG1 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RETREG1 mRNA more ... CTD PMID:17404688 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RETREG1 mRNA CTD PMID:18796159 and PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Retreg1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of RETREG1 mRNA CTD PMID:20819909 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Retreg1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of RETREG1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Retreg1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RETREG1 gene] CTD PMID:20819909 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Retreg1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of RETREG1 mRNA CTD PMID:19770486 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RETREG1 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RETREG1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO Retreg1 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of RETREG1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases methylation ISO RETREG1 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of RETREG1 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO Retreg1 (Mus musculus) 6480464 Fenretinide results in increased expression of RETREG1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FAM134B mRNA CTD PMID:30047161 aflatoxin B1 increases methylation ISO RETREG1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of FAM134B intron and Aflatoxin B1 results in increased methylation of RETREG1 gene CTD PMID:27153756 and PMID:30157460 aldehydo-D-glucose multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of RETREG1 protein CTD PMID:34801538 aldrin decreases expression ISO Retreg1 (Mus musculus) 6480464 Aldrin results in decreased expression of RETREG1 mRNA CTD PMID:18579281 antirheumatic drug decreases expression ISO RETREG1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of RETREG1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RETREG1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of RETREG1 mRNA CTD PMID:33212167 benzo[a]pyrene decreases expression ISO Retreg1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of RETREG1 mRNA CTD PMID:19770486 and PMID:22228805 benzo[a]pyrene decreases expression ISO RETREG1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of RETREG1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RETREG1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of FAM134B promoter CTD PMID:27901495 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of RETREG1 mRNA CTD PMID:26496021 bisphenol A increases expression ISO Retreg1 (Mus musculus) 6480464 bisphenol A results in increased expression of RETREG1 mRNA CTD PMID:32156529 and PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RETREG1 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RETREG1 mRNA CTD PMID:33296240 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FAM134B mRNA and bisphenol A affects the expression of RETREG1 mRNA CTD PMID:25181051 and PMID:32145629 buspirone increases expression EXP 6480464 Buspirone results in increased expression of RETREG1 mRNA CTD PMID:24136188 carbamazepine affects expression ISO RETREG1 (Homo sapiens) 6480464 Carbamazepine affects the expression of RETREG1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Retreg1 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of RETREG1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Retreg1 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of RETREG1 mRNA CTD PMID:25620056 chloroethene decreases expression ISO Retreg1 (Mus musculus) 6480464 Vinyl Chloride results in decreased expression of RETREG1 mRNA CTD PMID:18579281 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 cisplatin increases expression ISO RETREG1 (Homo sapiens) 6480464 Cisplatin results in increased expression of RETREG1 mRNA CTD PMID:27392435 and PMID:27594783 cisplatin multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of RETREG1 mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RETREG1 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of RETREG1 mRNA CTD PMID:19376846 copper atom multiple interactions ISO Retreg1 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RETREG1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO Retreg1 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RETREG1 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO Retreg1 (Mus musculus) 6480464 Copper Sulfate results in decreased expression of RETREG1 mRNA CTD PMID:18579281 cyclosporin A increases expression ISO RETREG1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of RETREG1 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO Retreg1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of RETREG1 mRNA CTD PMID:19770486 D-glucose multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of RETREG1 protein CTD PMID:34801538 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of RETREG1 mRNA CTD PMID:32679240 dexamethasone increases expression ISO RETREG1 (Homo sapiens) 6480464 Dexamethasone results in increased expression of RETREG1 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RETREG1 mRNA CTD PMID:28628672 diquat decreases expression ISO Retreg1 (Mus musculus) 6480464 Diquat results in decreased expression of RETREG1 protein CTD PMID:36851058 diuron decreases expression EXP 6480464 Diuron results in decreased expression of RETREG1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RETREG1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of RETREG1 mRNA CTD PMID:29803840 fenthion increases expression ISO Retreg1 (Mus musculus) 6480464 Fenthion results in increased expression of RETREG1 mRNA CTD PMID:34813904 furan increases expression EXP 6480464 furan results in increased expression of RETREG1 mRNA CTD PMID:26194646 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of RETREG1 mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RETREG1 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of RETREG1 mRNA CTD PMID:24136188 glucose decreases expression EXP 6480464 Glucose results in decreased expression of RETREG1 protein CTD PMID:34801538 glucose multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of RETREG1 protein] CTD PMID:34801538 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of RETREG1 mRNA CTD PMID:20621112 indometacin multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of RETREG1 mRNA CTD PMID:28628672 inulin multiple interactions ISO Retreg1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RETREG1 mRNA CTD PMID:36331819 iron dichloride decreases expression ISO RETREG1 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of RETREG1 mRNA CTD PMID:35984750 isotretinoin decreases expression ISO RETREG1 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of RETREG1 mRNA CTD PMID:20436886 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of RETREG1 mRNA CTD PMID:22641619 lead(0) affects expression ISO RETREG1 (Homo sapiens) 6480464 Lead affects the expression of RETREG1 mRNA CTD PMID:28903495 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of RETREG1 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RETREG1 mRNA CTD PMID:35811015 menadione affects expression ISO RETREG1 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of RETREG1 mRNA CTD PMID:20044591 mercury dibromide increases expression ISO RETREG1 (Homo sapiens) 6480464 mercuric bromide results in increased expression of RETREG1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of FAM134B mRNA CTD PMID:30467583 methimazole increases expression EXP 6480464 Methimazole results in increased expression of FAM134B mRNA CTD PMID:30047161 methylmercury chloride decreases expression ISO RETREG1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of RETREG1 mRNA CTD PMID:28001369 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital co-treated with Dietary Fats] results in increased expression of FAM134B protein CTD PMID:36657701 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of RETREG1 mRNA CTD PMID:24136188 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of RETREG1 mRNA and Nevirapine results in increased expression of RETREG1 mRNA CTD PMID:23947594 nickel sulfate increases expression ISO RETREG1 (Homo sapiens) 6480464 nickel sulfate results in increased expression of RETREG1 mRNA CTD PMID:22714537 O-methyleugenol decreases expression ISO RETREG1 (Homo sapiens) 6480464 methyleugenol results in decreased expression of RETREG1 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RETREG1 mRNA CTD PMID:25729387 paracetamol affects expression ISO Retreg1 (Mus musculus) 6480464 Acetaminophen affects the expression of RETREG1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RETREG1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of RETREG1 mRNA CTD PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of RETREG1 mRNA CTD PMID:32680482 parathion increases expression ISO Retreg1 (Mus musculus) 6480464 Parathion results in increased expression of RETREG1 mRNA CTD PMID:34813904 perfluorooctane-1-sulfonic acid multiple interactions ISO Retreg1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RETREG1 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RETREG1 mRNA CTD PMID:36331819 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital co-treated with Dietary Fats] results in increased expression of FAM134B protein CTD PMID:36657701 phenylmercury acetate increases expression ISO RETREG1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of RETREG1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RETREG1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Retreg1 (Mus musculus) 6480464 pirinixic acid results in increased expression of RETREG1 mRNA CTD PMID:17426115 potassium chromate increases expression ISO RETREG1 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of RETREG1 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO Retreg1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of RETREG1 mRNA CTD PMID:28903501 progesterone multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RETREG1 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of RETREG1 mRNA CTD PMID:17404688 and PMID:20660070 propanal increases expression ISO RETREG1 (Homo sapiens) 6480464 propionaldehyde results in increased expression of RETREG1 mRNA CTD PMID:26079696 propiconazole decreases expression ISO Retreg1 (Mus musculus) 6480464 propiconazole results in decreased expression of RETREG1 mRNA CTD PMID:21278054 raloxifene multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of RETREG1 mRNA CTD PMID:19059307 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RETREG1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RETREG1 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of RETREG1 mRNA CTD PMID:25895662 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RETREG1 mRNA CTD PMID:25993096 tamoxifen multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of RETREG1 mRNA CTD PMID:19059307 tamoxifen affects expression ISO Retreg1 (Mus musculus) 6480464 Tamoxifen affects the expression of RETREG1 mRNA CTD PMID:17555576 and PMID:20937368 temozolomide decreases expression ISO RETREG1 (Homo sapiens) 6480464 Temozolomide results in decreased expression of RETREG1 mRNA CTD PMID:31758290 tetrachloroethene increases expression ISO Retreg1 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of RETREG1 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO Retreg1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of RETREG1 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RETREG1 mRNA CTD PMID:31150632 tetrachloromethane affects expression ISO Retreg1 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of RETREG1 mRNA CTD PMID:17484886 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RETREG1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RETREG1 (Homo sapiens) 6480464 trichostatin A results in increased expression of RETREG1 mRNA CTD PMID:24935251 valproic acid affects expression ISO RETREG1 (Homo sapiens) 6480464 Valproic Acid affects the expression of RETREG1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RETREG1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of RETREG1 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RETREG1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA CTD PMID:27188386 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of RETREG1 mRNA CTD PMID:23034163 vitamin E decreases expression ISO RETREG1 (Homo sapiens) 6480464 Vitamin E results in decreased expression of RETREG1 mRNA CTD PMID:19244175 zoledronic acid increases expression ISO RETREG1 (Homo sapiens) 6480464 zoledronic acid results in increased expression of RETREG1 mRNA CTD PMID:24714768